CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chongqing Zhifei Biological Prdct Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chongqing Zhifei Biological Prdct Co Ltd
50F
No. 1 Qingyun Road, Jiangbei District
Phone: +86 2386358226p:+86 2386358226 CHONGQING, CHO  400020  China Ticker: 300122300122
Business Summary
Chongqing Zhifei Biological Products Co Ltd is a China-based company primarily engaged in the research and development, production, sales, distribution, and import and export of vaccines and biological products. The Company's main products include vaccines for preventing infectious diseases such as meningitis, cervical cancer, pneumonia, influenza, rotavirus, and shingles, as well as drugs that provide effective solutions for the diagnosis, prevention, and treatment of tuberculosis infection. The Company is also engaged in providing bonded warehousing, customs clearance filing, and batch issuance services for the imported vaccines. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board RenshengJiang 71 9/20/2024 8/1/2012
President, Vice Chairman of the Board LingfengJiang 44 9/20/2024 8/17/2009
Chief Financial Officer, Vice President, Director ZhenjingLi 42 8/19/2015 8/19/2015
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 7,220 (As of 12/31/2024)
Outstanding Shares: 2,393,789,747 (As of 9/30/2025)
Shareholders: 127,461
Stock Exchange: SHE
Fax Number: +86 2386358685


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, October 31, 2025